Avaí Bio, Inc. (AVAI)
OQB · Technology · Software - Application
$0.15
-1.32%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$20.7M
Shares Outstanding
138.3M
Exchange
OQB
Currency
USD
About Avaí Bio, Inc.
Avaí Bio, Inc. acquires, creates, and develops artificial intelligence (AI) technologies. It also offers information technology (IT) consulting services. The company provides full-stack software development, database management, data integration, project management and cloud services resources. Further, it offers Avant! AI, a platform that has shown impressive results related to the technology's usage, access, and performance; and InstantFAME. The company was formerly known as Avant Technologies Inc. and changed its name to Avaí Bio, Inc. in February 2026. Avaí Bio, Inc. was incorporated in 2017 and is based in Vilnius, Lithuania.
Quarterly Financials
| Metric | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 464K | -488K | -453K | -554K |
| Net Income | 464K | -488K | -453K | -554K |
| Diluted EPS | $nan | $0.00 | $0.00 | $0.00 |
Annual Financials
| Metric | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | 921K | 276K | 0.00 | 0.00 |
| Gross Profit | 211K | -40K | 0.00 | |
| Operating Income | -127K | -349K | -2.1M | -1.1M |
| Net Income | -127K | -349K | -2.1M | -1.1M |
| Diluted EPS | $-0.00 | $0.00 | $-0.02 | $-0.01 |